Bristol-Myers Squibb BMY
$61.83 −$0.31 (-0.49%)
Market open · Nov 10, 9:40 am ET · After hours $62.43 +0.47%
Open$61.75
Prev close$62.14
Day range$61.42 – $62.13
Volume274.5K
Market cap$126.40B
P/E (TTM)13.7
Dividend yield4.08%
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$13.07B+6.9% YoY
Operating profit$4.40B+20.9% YoY
Net profit$2.16B-1.5% YoY
Diluted EPS$1.05-2.8% YoY
Free cash flow$3.84B-36.0% YoY
Operating cash flow$4.18B
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin69.2%
Operating margin29.2%
Net margin18.5%
Return on equity44.1%
Return on assets10.0%
Return on invested capital15.4%
Current ratio1.59
Liabilities / assets73.6%
Cash & investments$12.58B
Total debt$44.59B
Net cash (debt)-$32.01B
Free cash flow / sales18.6%
Where the revenue comes from
Quarter 2026/Q3
By business line
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $13.07B | $12.97B | $11.49B | $48.19B | $12.50B |
| Total Operating Revenue | $13.07B | $12.97B | $11.49B | $48.20B | $12.50B |
| Cost of Revenue | $4.15B | $3.73B | $3.42B | $13.94B | $4.10B |
| Gross Profit | $8.92B | $9.25B | $8.07B | $34.26B | $8.41B |
| Operating Expense | $4.52B | $5.22B | $4.70B | $20.54B | $5.59B |
| Selling and Admin Expenses | $1.70B | $1.83B | $1.62B | $7.27B | $2.18B |
| Research & Development | $2.37B | $2.96B | $2.65B | $9.95B | $2.59B |
| Depreciation & Amortization & Depletion | $458.00M | $437.00M | $437.00M | $3.32B | $826.00M |
| -Depreciation & Amortization | $458.00M | $437.00M | $437.00M | $3.32B | $826.00M |
| Operating Profit | $4.40B | $4.03B | $3.37B | $13.72B | $2.81B |
| Net Non-Operating Interest Income (Expense) | -$403.00M | -$407.00M | -$411.00M | -$1.89B | -$432.00M |
| Non-Operating Interest Expense | $403.00M | $407.00M | $411.00M | $1.89B | $432.00M |
| Other Income (Expense) | -$1.46B | $467.00M | $284.00M | -$2.50B | -$909.00M |
| Gain on Sale of Security | $92.00M | $215.00M | $238.00M | $510.00M | -$18.00M |
| Special Income (Charges) | -$1.76B | $60.00M | -$122.00M | -$5.23B | -$1.59B |
| -Less:Restructuring and Mergern & Acquisition | $1.76B | $73.00M | $118.00M | $4.79B | $1.59B |
| -Less:Other Special Charges | $3.00M | $5.00M | $4.00M | $434.00M | $10.00M |
| -Gain on Sale Of Business | $0.00 | $138.00M | – | – | – |
| Other Non-Operating Income (Expenses) | $204.00M | $192.00M | $168.00M | $2.21B | $703.00M |
| Pretax Profit | $2.54B | $4.09B | $3.24B | $9.33B | $1.47B |
| Tax | $374.00M | $770.00M | $561.00M | $2.27B | $384.00M |
| Net Profit | $2.16B | $3.32B | $2.68B | $7.06B | $1.09B |
| Profit from Continuing Operations | $2.16B | $3.32B | $2.68B | $7.06B | $1.09B |
| Minority Interests | $0.00 | -$1.00M | $1.00M | $2.00M | -$1.00M |
| Net Income to Parent Company | $2.16B | $3.32B | $2.68B | $7.05B | $1.09B |
| Net Income to Common Stockholders | $2.16B | $3.32B | $2.68B | $7.05B | $1.09B |
| Basic EPS | $1.06 | $1.62 | $1.31 | $3.47 | $0.53 |
| Diluted EPS | $1.05 | $1.62 | $1.31 | $3.46 | $0.53 |
| Dividend Per Share | $0.63 | $0.63 | $0.63 | $2.49 | $0.63 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $88.77B | $87.63B | $86.48B | $90.04B | $90.04B |
| Total Current Assets | $29.77B | $28.58B | $27.21B | $29.39B | $29.39B |
| Cash and Cash Equivalents & Short-Term Investments | $12.58B | $11.07B | $10.49B | $10.67B | $10.67B |
| -Cash and Cash Equivalents | $9.57B | $8.72B | $9.57B | $10.21B | $10.21B |
| -Short Term Investments | $3.01B | $2.35B | $912.00M | $464.00M | $464.00M |
| Receivables | $12.85B | $13.00B | $12.08B | $14.53B | $14.53B |
| -Accounts Receivable | $9.19B | $9.08B | $7.95B | $9.59B | $9.59B |
| -Taxes Receivable | $2.13B | $2.34B | $2.57B | $2.92B | $2.92B |
| -Other Receivables | $1.53B | $1.58B | $1.57B | $2.01B | $2.01B |
| Inventory | $2.70B | $2.74B | $2.76B | $2.69B | $2.69B |
| Other Current Assets | $1.63B | $1.78B | $1.88B | $1.50B | $1.50B |
| Total Non-Current Assets | $59.00B | $59.06B | $59.27B | $60.65B | $60.65B |
| Net PPE | $9.45B | $9.28B | $9.19B | $9.13B | $9.13B |
| -Gross PPE | $15.14B | $14.83B | $14.62B | $14.42B | $14.42B |
| -Accumulated Depreciation | -$5.69B | -$5.55B | -$5.43B | -$5.29B | -$5.29B |
| Investments and Advances | $2.32B | $2.39B | $2.24B | $2.51B | $2.51B |
| -Held to Maturity Securities | $378.00M | – | – | $15.00M | $15.00M |
| -Long Term Equity Investment | $1.94B | $1.99B | $1.88B | $2.10B | $2.10B |
| Goodwill and Other Intangible Assets | $38.90B | $39.37B | $40.23B | $41.11B | $41.11B |
| -Goodwill | $21.74B | $21.74B | $21.74B | $21.75B | $21.75B |
| -Other Intangible Assets | $17.17B | $17.63B | $18.49B | $19.35B | $19.35B |
| Defined Pension Benefit | $335.00M | $332.00M | $330.00M | $330.00M | $330.00M |
| Non-Current Deferred Assets | $5.88B | $5.36B | $5.18B | $5.38B | $5.38B |
| Other Non-Current Assets | $2.11B | $2.33B | $2.10B | $2.20B | $2.20B |
| Total Liabilities | $65.37B | $65.32B | $66.37B | $71.53B | $71.53B |
| Total Current Liabilities | $18.75B | $18.66B | $19.16B | $23.42B | $23.42B |
| Payables | $6.64B | $6.25B | $6.43B | $5.84B | $5.84B |
| -Accounts Payable | $4.63B | $4.16B | $4.23B | $3.58B | $3.58B |
| -Total Tax Payable | $727.00M | $806.00M | $909.00M | $979.00M | $979.00M |
| -Dividends Payable | $1.29B | $1.29B | $1.29B | $1.28B | $1.28B |
| Current Accrued Expenses | $589.00M | $587.00M | $507.00M | $484.00M | $484.00M |
| Short-Term Debt and Capital Lease Obligation | $1.25B | $1.23B | $2.51B | $2.46B | $2.46B |
| -Current Debt | $1.03B | $1.03B | $2.31B | $2.26B | $2.26B |
| -Current Capital Lease Obligation | $220.00M | $207.00M | $199.00M | $202.00M | $202.00M |
| Other Current Liabilities | $9.15B | $9.71B | $9.22B | $13.07B | $13.07B |
| Total Non-Current Liabilities | $46.62B | $46.66B | $47.22B | $48.12B | $48.12B |
| Long Term Accounts Payable and Other Payables | $900.00M | $830.00M | $1.31B | $1.41B | $1.41B |
| Long Term Debt and Capital Lease Obligation | $43.56B | $43.82B | $43.92B | $44.68B | $44.68B |
| -Long Term Debt | $41.85B | $42.09B | $42.15B | $42.85B | $42.85B |
| -Long Term Capital Lease Obligation | $1.71B | $1.73B | $1.77B | $1.83B | $1.83B |
| Non-Current Deferred Liabilities | $870.00M | $885.00M | $842.00M | $878.00M | $878.00M |
| Employee Benefits | $299.00M | $307.00M | $317.00M | $330.00M | $330.00M |
| Other Non-Current Liabilities | $984.00M | $815.00M | $824.00M | $824.00M | $824.00M |
| Total Equity | $23.40B | $22.32B | $20.10B | $18.51B | $18.51B |
| Stockholders' Equity | $23.40B | $22.32B | $20.07B | $18.47B | $18.47B |
| Capital Stock | $292.00M | $292.00M | $292.00M | $292.00M | $292.00M |
| -Common Stock | $292.00M | $292.00M | $292.00M | $292.00M | $292.00M |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $46.67B | $46.50B | $46.37B | $46.39B | $46.39B |
| Retained Earnings | $21.19B | $20.32B | $18.29B | $16.90B | $16.90B |
| Less: Treasury Stock | $43.47B | $43.50B | $43.52B | $43.58B | $43.58B |
| Gains/Losses Not Affecting Retained Earnings | -$1.28B | -$1.29B | -$1.37B | -$1.52B | -$1.52B |
| Minority Interests | $0.00 | $0.00 | $34.00M | $33.00M | $33.00M |
| -Available for Sale Securities | – | $397.00M | $366.00M | $396.00M | $396.00M |
| Other Equity Interests | – | $1.00M | – | – | – |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $4.18B | $3.39B | $1.10B | $14.16B | $1.97B |
| Net cash flow from continuing operations | $4.18B | $3.39B | $1.10B | $14.16B | $1.97B |
| Net Income from Continuing Operations | $2.16B | $3.32B | $2.68B | $7.06B | $1.09B |
| Gain/Loss from Continuing Operations | $16.00M | -$256.00M | -$168.00M | -$1.45B | -$475.00M |
| Depreciation & Depletion & Amortization | $626.00M | $594.00M | $594.00M | $4.01B | $977.00M |
| Deferred Tax | -$510.00M | -$195.00M | $161.00M | -$965.00M | -$392.00M |
| Other Non-Cash Items | $1.56B | $1.00M | $115.00M | $4.30B | $1.72B |
| Change in Working Capital | $193.00M | -$624.00M | -$2.83B | -$455.00M | -$1.65B |
| -Change in Receivables | -$95.00M | -$1.18B | $1.69B | -$295.00M | $19.00M |
| -Change in Inventory | $133.00M | -$36.00M | $14.00M | -$184.00M | $71.00M |
| -Change in Payables and Accrued Expense | $447.00M | -$551.00M | $596.00M | -$6.00M | -$414.00M |
| -Change In Other Working Capital | -$292.00M | $1.15B | -$5.13B | $30.00M | -$1.33B |
| Net cash flow from investing | -$2.10B | -$1.61B | -$131.00M | -$4.13B | -$1.46B |
| Net Cash Flow from Continuing Investing Activities | -$2.10B | -$1.61B | -$131.00M | -$4.13B | -$1.46B |
| Capital Expenditure | -$344.00M | -$305.00M | -$347.00M | -$1.31B | -$370.00M |
| Net Business Purchase and Sale | -$1.12B | $118.00M | $247.00M | -$2.87B | -$1.43B |
| Net Investment Purchase and Sale | -$639.00M | -$1.43B | -$31.00M | $52.00M | $340.00M |
| Financing Cash Flow | -$1.22B | -$2.63B | -$1.56B | -$10.35B | -$6.03B |
| Net Cash Flow from Continuing Financing Activities | -$1.22B | -$2.63B | -$1.56B | -$10.35B | -$6.03B |
| Net Issuance Payments Of Debt | -$1.00M | -$1.35B | -$179.00M | -$5.18B | -$4.73B |
| Cash Dividends Paid | -$1.29B | -$1.29B | -$1.28B | -$5.05B | -$1.26B |
| Proceeds from Stock Option Exercised | $66.00M | $7.00M | -$98.00M | -$128.00M | -$33.00M |
| Ending Cash Balance | $9.57B | $8.72B | $9.58B | $10.22B | $10.22B |
| Net Change in Cash | $855.00M | -$851.00M | -$587.00M | -$324.00M | -$5.51B |
| Beginning Cash Balance | $8.72B | $9.58B | $10.22B | $10.35B | $15.73B |
| Effect of Exchange Rate Changes | -$3.00M | -$10.00M | -$48.00M | $195.00M | $5.00M |
| Free Cash Flow | $3.84B | $3.09B | $757.00M | $12.85B | $1.60B |
| Net Common Stock Issuance | – | – | – | $0.00 | – |
No comments yet — be the first to weigh in on BMY.
Sign in to join the discussion.